Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Repligen
RGEN
$9.42B
| $13.4M | ﹤0.01% |
82,609
+54,625
| +195% | +$8.64M |
|
2227
HUB Group
HUBG
$2.46B
| $13.4M | ﹤0.01% |
378,168
+281,282
| +290% | +$9.85M |
|
2228
CALL
CSX Corp
CSX
$92.9B
| $13.4M | ﹤0.01% |
461,300
-228,300
| -33% | -$7.44M |
|
2229
CALL
Campbell Soup
CPB
$6.91B
| $13.4M | ﹤0.01% |
278,800
-166,200
| -37% | -$7.83M |
|
2230
Ingredion
INGR
$6.63B
| $13.4M | ﹤0.01% |
151,927
+29,166
| +24% | +$2.61M |
|
2231
Westlake Corp
WLK
$10.2B
| $13.4M | ﹤0.01% |
136,639
-70,317
| -34% | -$8.61M |
|
2232
Bilibili
BILI
$7.3B
| $13.4M | ﹤0.01% |
522,637
+246,704
| +89% | +$5.93M |
|
|
DQ
2233
CALL
Daqo New Energy
DQ
$991M
| $13.4M | ﹤0.01% |
187,200
+129,700
| +226% | +$6.44M |
|
2234
Toro Company
TTC
$9.37B
| $13.4M | ﹤0.01% |
176,167
+144,814
| +462% | +$11.8M |
|
2235
PUT
Copart
CPRT
$29.3B
| $13.3M | ﹤0.01% |
490,000
-1,200
| -0.2% | -$34.2K |
|
2236
Aclaris Therapeutics
ACRS
$851M
| $13.3M | ﹤0.01% |
953,072
-19,128
| -2% | -$268K |
|
2237
PUT
FMC
FMC
$1.27B
| $13.3M | ﹤0.01% |
124,200
+60,100
| +94% | +$7.34M |
|
2238
iShares Global REIT ETF
REET
$5.09B
| $13.3M | ﹤0.01% |
548,473
+513,231
| +1,456% | +$13.7M |
|
2239
CALL
Restaurant Brands International
QSR
$27.1B
| $13.3M | ﹤0.01% |
264,400
+57,200
| +28% | +$3.06M |
|
2240
DigitalOcean
DOCN
$15.3B
| $13.2M | ﹤0.01% |
319,780
+106,594
| +50% | +$4.75M |
|
2241
PUT
Harley-Davidson
HOG
$2.89B
| $13.2M | ﹤0.01% |
417,600
+82,200
| +25% | +$2.92M |
|
2242
CALL
Incyte
INCY
$24.4B
| $13.2M | ﹤0.01% |
174,000
-70,400
| -29% | -$5.35M |
|
2243
CALL
State Street SPDR S&P Bank ETF
KBE
$1.76B
| $13.2M | ﹤0.01% |
301,200
-37,400
| -11% | -$1.78M |
|
2244
PUT
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $13.2M | ﹤0.01% |
440,800
+363,900
| +473% | +$11.7M |
|
2245
Mine Safety
MSA
$7.3B
| $13.2M | ﹤0.01% |
108,903
+88,762
| +441% | +$11M |
|
2246
PUT
Builders FirstSource
BLDR
$7.8B
| $13.2M | ﹤0.01% |
245,300
-5,200
| -2% | -$319K |
|
2247
Teledyne Technologies
TDY
$31.5B
| $13.2M | ﹤0.01% |
35,107
-88,762
| -72% | -$37M |
|
2248
CALL
Martin Marietta Materials
MLM
$32.9B
| $13.2M | ﹤0.01% |
44,000
-62,500
| -59% | -$21.3M |
|
2249
Macerich
MAC
$7.01B
| $13.2M | ﹤0.01% |
1,511,271
+731,372
| +94% | +$8.84M |
|
2250
Arrowhead Research
ARWR
$12.2B
| $13.2M | ﹤0.01% |
373,697
+173,773
| +87% | +$6.54M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.